Treatment Information

Back

Liver Cancer treatment details. Biologic therapy.

AKH and Medizinische Universität Wien, Wien, Austria.

Survival: monthsCountry:Austria
Toxiciy Grade:4City/State/Province:Wien
Treatments:Biologic therapyHospital:AKH and Medizinische Universität Wien
Drugs:Journal:Link
Date:Oct 2008

Description:

Patients:
This phase 2 study involved 28 advanced hepatocellular carcinoma patients. The median patient age was 65 years and 86% were male.

Treatment:
Patients were treated with the biologic therapy agent thalidomide.

Toxicities:
The most severe toxicities were of grade 4 and included grade 3-4 fatigue, dizziness, skin rash, and constipation.

Results:
The median overall survival was 5.1 months.

Correspondence: Dr. Markus Peck-Radosavljevic; email: [email protected]



Back